Interphex on Tap - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Interphex on Tap
The 2011 show presents ideas for package designs and equipment options for packaging lines.


Pharmaceutical Technology
Volume 35, Issue 3, pp. 44-48

Single-use systems


Symetix Secure Connection enables remote diagnostics for VeriSym and OptyxSG inspection systems. (PHOTO IS COURTESY OF SYMETIX.)
A range of end-ported biocontainers meet the growing demand for single-use systems that reduce cleaning requirements and downtime. Available in 50-, 250-, and 500-mL sizes as well as 1-, 2-, 5-, 10-, and 20-L sizes, the polyethylene-based containers offer high gas and water-vapor barrier properties. Custom designs also are available. Biocontainers may be ordered with silicone or thermoplastic elastomer tubing with various connections, and can be specified with or without filter capsules. Certified to be free of animal components, the containers are packaged in an ISO Class 7 cleanroom (TepoFlex biocontainers, Meissner Filtration Products).

Quality-control devices

A direct connection between machine and machine builder provides remote access to inspection equipment even if the system is located behind a firewall. The secure link enables remote diagnostics to be conducted and supplies data, images, and other information. If permission is granted, original equipment company engineers can access the machine's user interface, data, images, and logs. Setup is simple and saves the days of engineering and administrative time usually needed to provide access to a machine.

The connection also archives logs and setup parameters securely and makes it possible to transmit logs and batch records to any computer with a network connection. The connection service can be purchased alone or as part of a service package that includes replacement parts and an annual on-site machine audit by a field engineer (Symetix Secure Connection service for VeriSym and OptyxSG inspection systems, Symetix).

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here